Exact Mass: 336.0109

Exact Mass Matches: 336.0109

Found 181 metabolites which its exact mass value is equals to given mass value 336.0109, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

peonidin

1-Benzopyrylium, 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-, chloride

C16H13ClO6 (336.0401)


Peonidin chloride is an anthocyanidin chloride that has peonidin as the cationic component. It has a role as a metabolite, an antineoplastic agent, an apoptosis inducer and an antioxidant. It contains a peonidin. An anthocyanidin chloride that has peonidin as the cationic component.

   

Bisphenol AF

4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenol

C15H10F6O2 (336.0585)


CONFIDENCE standard compound; INTERNAL_ID 380; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4798; ORIGINAL_PRECURSOR_SCAN_NO 4796 CONFIDENCE standard compound; INTERNAL_ID 380; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4887; ORIGINAL_PRECURSOR_SCAN_NO 4885 CONFIDENCE standard compound; INTERNAL_ID 380; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4799; ORIGINAL_PRECURSOR_SCAN_NO 4798 CONFIDENCE standard compound; INTERNAL_ID 380; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4824; ORIGINAL_PRECURSOR_SCAN_NO 4819 CONFIDENCE standard compound; INTERNAL_ID 380; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4817; ORIGINAL_PRECURSOR_SCAN_NO 4812 CONFIDENCE standard compound; INTERNAL_ID 380; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4468; ORIGINAL_PRECURSOR_SCAN_NO 4466 D052244 - Endocrine Disruptors

   

Nicotinic acid mononucleotide

3-carboxy-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-1lambda5-pyridin-1-ylium

[C11H15NO9P]+ (336.0484)


Nicotinic acid mononucleotide, also known as nicotinate ribonucleotide, belongs to the class of organic compounds known as nicotinic acid nucleotides. These are pyridine nucleotides in which the pyridine base is nicotinic acid or a derivative thereof. Nicotinic acid mononucleotide is an extremely weak basic (essentially neutral) compound (based on its pKa). Nicotinic acid mononucleotide an intermediate in the cofactor biosynthesis and the nicotinate and nicotinamide metabolism pathways. It is a substrate for nicotinamide riboside kinase, ectonucleotide pyrophosphatase/phosphodiesterase, nicotinamide mononucleotide adenylyltransferase, 5-nucleotidase, nicotinate-nucleotide pyrophosphorylase, and 5(3)-deoxyribonucleotidase. Nicotinic acid mononucleotide is an intermediate in the metabolism of Nicotinate and nicotinamide. It is a substrate for Ectonucleotide pyrophosphatase/phosphodiesterase 2, Ectonucleotide pyrophosphatase/phosphodiesterase 1, Nicotinamide mononucleotide adenylyltransferase 3, Cytosolic 5-nucleotidase IA, Cytosolic 5-nucleotidase IB, Nicotinate-nucleotide pyrophosphorylase, 5(3)-deoxyribonucleotidase (cytosolic type), Cytosolic purine 5-nucleotidase, Nicotinamide mononucleotide adenylyltransferase 2, Ectonucleotide pyrophosphatase/phosphodiesterase 3, 5-nucleotidase, 5(3)-deoxyribonucleotidase (mitochondrial) and Nicotinamide mononucleotide adenylyltransferase 1. [HMDB] NaMN is the most common mononucleotide intermediate (a hub) in NAD biogenesis. For example, in E. coli all three pyridine precursors are converted into NaMN (Table 1 and Figure 3(a)). Qa produced by the de novo Asp–DHAP pathway (genes nadB and nadA) is converted into NaMN by QAPRT (gene nadC). Salvage of both forms of niacin proceeds via NAPRT (gene pncB) either directly upon or after deamidation by NMDSE (gene pncA). Overall, more than 90\% of approximately 680 analyzed bacterial genomes contain at least one of the pathways leading to the formation of NaMN. Most of them (∼480 genomes) have the entire set of nadBAC genes for NaMN de novo synthesis from Asp that are often clustered on the chromosome and/or are co-regulated by the same transcription factors (see Section 7.08.3.1.2). Among the examples provided in Table 1, F. tularensis (Figure 4(c)) has all three genes of this de novo pathway forming a single operon-like cluster and supporting the growth of this organism in the absence of any pyridine precursors in the medium. More than half the genomes with the Asp–DHAP pathway also contain a deamidating niacin salvage pathway (genes pncAB) as do many representatives of the α-, β-, and γ-Proteobacteria, Actinobacteria, and Bacillus/Clostridium group. As already emphasized, the genomic reconstruction approach provides an assessment of the metabolic potential of an organism, which may or may not be realized under given conditions. For example, E. coli and B. subtilis can utilize both de novo and PncAB Nm salvage pathways under the same growth conditions, whereas in M. tuberculosis (having the same gene pattern) the latter pathway was considered nonfunctional, so that the entire NAD pool is generated by the de novo NadABC route. However, a recent study demonstrated the functional activity of the Nm salvage pathway in vivo, under hypoxic conditions in infected macrophages.221 This study also implicated the two downstream enzymes of NAD synthesis (NAMNAT and NADSYN) as attractive chemotherapeutic targets to treat acute and latent forms of tuberculosis. In approximately 100 species, including many Cyanobacteria (e.g., Synechococcus spp.), Bacteroidetes (e.g., Chlorobium spp.) and Proteobacteria (e.g., Caulobacter crescentus, Zymomonas mobilis, Desulfovibrio spp., and Shewanella spp. representing α-, β-, δ-, and γ-groups, respectively) the Asp–DHAP pathway is the only route to NAD biogenesis. Among them, nearly all Helicobacter spp. (except H. hepaticus), contain only the two genes nadA and nadC but lack the first gene of the pathway (nadB), which is a likely subject of nonorthologous gene replacement. One case of NadB (ASPOX) replacement by the ASPDH enzyme in T. maritima (and methanogenic archaea) was discussed in Section 7.08.2.1. However, no orthologues of the established ASPDH could be identified in Helicobacter spp. as well as in approximately 15 other diverse bacterial species that have the nadAC but lack the nadB gene (e.g., all analyzed Corynebacterium spp. except for C. diphtheriae). Therefore, the identity of the ASPOX or ASPDH enzyme in these species is still unknown, representing one of the few remaining cases of ‘locally missing genes’220 in the NAD subsystem. All other bacterial species contain either both the nadA and nadB genes (plus nadC) or none. In a limited number of bacteria (∼20 species), mostly in the two distant groups of Xanthomonadales (within γ-Proteobacteria) and Flavobacteriales (within Bacteroidetes), the Asp–DHAP pathway of Qa synthesis is replaced by the Kyn pathway. As described in Section 7.08.2.1.2, four out of five enzymes (TRDOX, KYNOX, KYNSE, and HADOX) in the bacterial version of this pathway are close homologues of the respective eukaryotic enzymes, whereas the KYNFA gene is a subject of multiple nonorthologous replacements. Although the identity of one alternative form of KYNFA (gene kynB) was established in a group of bacteria that have a partial Kyn pathway for Trp degradation to anthranilate (e.g., in P. aeruginosa or B. cereus57), none of the known KYNFA homologues are present in Xanthomonadales or Flavobacteriales. In a few species (e.g., Salinispora spp.) a complete gene set of the Kyn pathway genes co-occurs with a complete Asp–DHAP pathway. Further experiments would be required to establish to what extent and under what conditions these two pathways contribute to Qa formation. As discussed, the QAPRT enzyme is shared by both de novo pathways, and a respective gene, nadC is always found in the genomes containing one or the other pathway. Similarly, gene nadC always co-occurs with Qa de novo biosynthetic genes with one notable exception of two groups of Streptococci, S. pneumonaie and S. pyogenes. Although all other members of the Lactobacillales group also lack the Qa de novo biosynthetic machinery and rely entirely on niacin salvage, only these two human pathogens contain a nadC gene. The functional significance of this ‘out of context’ gene is unknown, but it is tempting to speculate that it may be involved in a yet-unknown pathway of Qa salvage from the human host. Among approximately 150 bacterial species that lack de novo biosynthesis genes and rely on deamidating salvage of niacin (via NAPRT), the majority (∼100) are from the group of Firmicutes. Such a functional variant (illustrated for Staphylococcus aureus in Figure 4(b)) is characteristic of many bacterial pathogens, both Gram-positive and Gram-negative (e.g., Brucella, Bordetella, and Campylobacter spp. from α-, β-, and δ-Proteobacteria, Borrelia, and Treponema spp. from Spirochaetes). Most of the genomes in this group contain both pncA and pncB genes that are often clustered on the chromosome and/or are co-regulated (see Section 7.08.3.1.2). In some cases (e.g., within Mollicutes and Spirochaetales), only the pncB, but not the pncA gene, can be reliably identified, suggesting that either of these species can utilize only the deamidated form of niacin (Na) or that some of them contain an alternative (yet-unknown) NMASE. Although the nondeamidating conversion of Nm into NMN (via NMPRT) appears to be present in approximately 50 bacterial species (mostly in β- and γ-Proteobacteria), it is hardly ever the only route of NAD biogenesis in these organisms. The only possible exception is observed in Mycoplasma genitalium and M. pneumoniae that contain the nadV gene as the only component of pyridine mononucleotide biosynthetic machinery. In some species (e.g., in Synechocystes spp.), the NMPRT–NMNAT route is committed primarily to the recycling of endogenous Nm. On the other hand, in F. tularensis (Figure 4(c)), NMPRT (gene nadV) together with NMNAT (of the nadM family) constitute the functional nondeamidating Nm salvage pathway as it supports the growth of the nadE′-mutant on Nm but not on Na (L. Sorci et al., unpublished). A similar nondeamidating Nm salvage pathway implemented by NMPRT and NMNAT (of the nadR family) is present in some (but not all) species of Pasteurellaceae in addition to (but never instead of) the RNm salvage pathway (see below), as initially demonstrated for H. ducreyi.128 A two-step conversion of NaMN into NAD via a NaAD intermediate (Route I in Figure 2) is present in the overwhelming majority of bacteria. The signature enzyme of Route I, NAMNAT of the NadD family is present in nearly all approximately 650 bacterial species that are expected to generate NaMN via de novo or salvage pathways (as illustrated by Figures 3(a) and 3(b)). All these species, without a single exception, also contain NADSYN (encoded by either a short or a long form of the nadE gene), which is required for this route. The species that lack the NadD/NadE signature represent several relatively rare functional variants, including: 1. Route I of NAD synthesis (NaMN → NaAD → NAD) variant via a bifunctional NAMNAT/NMNAT enzyme of the NadM family is common for archaea (see Section 7.08.3.2), but it appears to be present in only a handful of bacteria, such as Acinetobacter, Deinococcus, and Thermus groups. Another unusual feature of the latter two groups is the absence of the classical NADKIN, a likely subject of a nonorthologous replacement that remains to be elucidated. 2. Route II of NAD synthesis (NaMN → NMN → NAD). This route is implemented by a combination of the NMNAT of either the NadM family (as in F. tularensis) or the NadR family (as in M. succinoproducens and A. succinogenes) with NMNSYN of the NadE′ family. The case of F. tularensis described in Section 7.08.2.4 is illustrated in Figure 3(b). The rest of the NAD biosynthetic machinery in both species from the Pasteurellaceae group, beyond the shared Route II, is remarkably different from that in F. tularensis. Instead of de novo biosynthesis, they harbor a Na salvage pathway via NAPRT encoded by a pncB gene that is present in a chromosomal cluster with nadE′. Neither of these two genes are present in other Pasteurellaceae that lack the pyridine carboxylate amidation machinery (see below). 3. Salvage of RNm (RNm → NMN → NAD). A genomic signature of this pathway, a combination of the PnuC-like transporter and a bifunctional NMNAT/RNMKIN of the NadR family, is present in many Enterobacteriaceae and in several other diverse species (e.g., in M. tuberculosis). However, in H. influenzae (Figure 3(d)) and related members of Pasteurellaceae, it is the only route of NAD biogenesis. As shown in Table 1, H. influenzae as well as many other members of this group have lost nearly all components of the rich NAD biosynthetic machinery that are present in their close phylogenetic neighbors (such as E. coli and many other Enterobacteriaceae). This pathway is an ultimate route for utilization of the so called V-factors (NADP, NAD, NMN, or RNm) that are required to support growth of H. influenzae. It was established that all other V-factors are degraded to RNm by a combination of periplasmic- and membrane-associated hydrolytic enzymes.222 Although PnuC was initially considered an NMN transporter,223 its recent detailed analysis in both H. influenzae and Salmonella confirmed that its actual physiological function is in the uptake of RNm coupled with the phosphorylation of RNM to NMN by RNMKIN.17,148,224 As already mentioned, H. ducreyi and several other V-factor-independent members of the Pasteurellaceae group (H. somnus, Actinobacillus pleuropneumoniae, and Actinomycetemcomitans) harbor the NMNAT enzyme (NadV) that allows them to grow in the presence of Nm (but not Na) in the medium (Section 7.08.2.2). 4. Uptake of the intact NAD. Several groups of phylogenetically distant intracellular endosymbionts with extremely truncated genomes contain only a single enzyme, NADKIN, from the entire subsystem. Among them are all analyzed species of the Wolbachia, Rickettsia, and Blochmannia groups. These species are expected to uptake and utilize the intact NAD from their host while retaining the ability to convert it into NADP. Among all analyzed bacteria, only the group of Chlamydia does not have NADKIN and depends on the salvage of both NAD and NADP via a unique uptake system.157 A comprehensive genomic reconstruction of the metabolic potential (gene annotations and asserted pathways) across approximately 680 diverse bacterial genomes sets the stage for the accurate cross-genome projection and prediction of regulatory mechanisms that control the realization of this potential in a variety of species and growth conditions. In the next section, we summarize the recent accomplishments in the genomic reconstruction of NAD-related regulons in bacteria. Nicotinic acid mononucleotide. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=321-02-8 (retrieved 2024-06-29) (CAS RN: 321-02-8). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

6-nitro-2,3-dioxo-1H,2H,3H,4H-benzo[f]quinoxaline-7-sulfonamide

C12H8N4O6S (336.0165)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002491 - Central Nervous System Agents > D000927 - Anticonvulsants NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist. NBQX has neuroprotective and anticonvulsant activity[1].

   
   

1,7-Diphospho-1-epi-valienol

1,7-Diphospho-1-epi-valienol

C7H14O11P2 (336.0011)


   

Dantrolene sodium

Dantrolene sodium anhydrous

C14H9N4NaO5 (336.0471)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents D002491 - Central Nervous System Agents

   

4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-methyl-O-sulphate

({[5-(3,4-dihydroxyphenyl)-4-hydroxypentanoyl]oxy}methoxy)sulphonic acid

C12H16O9S (336.0515)


4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-methyl-O-sulphate belongs to the family of Hydroxy Fatty Acids. These are fatty acids in which the chain bears an hydroxyl group.

   

8-(p-Sulfophenyl)theophylline

4-(1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)benzene-1-sulfonic acid

C13H12N4O5S (336.0528)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists

   

3-Benzyl-1-methyl-2,6-dioxo-7H-purine-8-sulfonic acid

3-Benzyl-1-methyl-2,6-dioxo-2,3,6,9-tetrahydro-1H-purine-8-sulphonic acid

C13H12N4O5S (336.0528)


   

Thiamine hydrochloride

3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium hydrochloride chloride

C12H18Cl2N4OS (336.0578)


Nutrient supplement; flavouring ingredient with a bitter taste. Thiamine hydrochloride is found in many foods, some of which are sesame, cinnamon, garden rhubarb, and nougat. Thiamine hydrochloride (Thiamine chloride hydrochloride) is an essential micronutrient needed as a cofactor for many central metabolic enzymes. Thiamine hydrochloride (Thiamine chloride hydrochloride) is an essential micronutrient needed as a cofactor for many central metabolic enzymes.

   

Disodium ethylenediaminetetraacetate

disodium 2-({2-[(carboxylatomethyl)(carboxymethyl)amino]ethyl}(carboxymethyl)amino)acetate

C10H14N2Na2O8 (336.0546)


Sequestrant, preservative and discolouration inhibitor for foods. Ethylenediaminetetraacetic acid, widely abbreviated as EDTA, is a polyamino carboxylic acid and a colourless, water-soluble solid. Its conjugate base is named ethylenediaminetetraacetate. It is widely used to dissolve limescale. Its usefulness arises because of its role as a hexadentate ("six-toothed") ligand and chelating agent Sequestrant, preservative and discolouration inhibitor for foods

   

beta-D-fructose 2,6-bisphosphate

[3,4-Dihydroxy-5-(hydroxymethyl)-5-(phosphonatooxy)oxolan-2-yl]methyl phosphoric acid

C6H10O12P2 (335.9648)


beta-d-fructose 2,6-bisphosphate is soluble (in water) and an extremely strong acidic compound (based on its pKa). beta-d-fructose 2,6-bisphosphate can be found in a number of food items such as chinese mustard, mexican oregano, chickpea, and saskatoon berry, which makes beta-d-fructose 2,6-bisphosphate a potential biomarker for the consumption of these food products.

   

[1S-[1a(Z),3a,4b]]-3-(3-Bromo-4-chloro-4-methylcyclohexyl)-4-oxo-2-pentenoic acid methyl ester

[1S-[1a(Z),3a,4b]]-3-(3-Bromo-4-chloro-4-methylcyclohexyl)-4-oxo-2-pentenoic acid methyl ester

C13H18BrClO3 (336.0128)


   
   

4,5-Dichloronorlichexanthone

4,5-Dichloronorlichexanthone

C14H18Cl2O5 (336.0531)


   

Methyl digallate ester

Methyl digallate ester

C15H12O9 (336.0481)


   

Maybridge3_004624

Maybridge3_004624

C18H12N2O3S (336.0569)


   
   
   
   
   

(-)-4-(1-p-Tolylmercapto-aethylsulfon)-benzoesaeure|(-)-4-(1-p-tolylsulfanyl-ethanesulfonyl)-benzoic acid

(-)-4-(1-p-Tolylmercapto-aethylsulfon)-benzoesaeure|(-)-4-(1-p-tolylsulfanyl-ethanesulfonyl)-benzoic acid

C16H16O4S2 (336.049)


   

Octahydroxyanthraquinone

Octahydroxyanthraquinone

C14H8O10 (336.0117)


   

Nicotinic acid mono nucleotide

Nicotinic acid mono nucleotide

[C11H15NO9P]+ (336.0484)


   

nicotinate beta-D-ribonucleotide

3-carboxy-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-1$l^{5}-pyridin-1-ylium

C11H15NO9P (336.0484)


   

7-iodo-9h-fluorene-4-carboxylic acid

7-iodo-9h-fluorene-4-carboxylic acid

C14H9IO2 (335.9647)


   

3,5-diphenyl-2-sulfanylidene-1H-thieno[2,3-d]pyrimidin-4-one

3,5-diphenyl-2-sulfanylidene-1H-thieno[2,3-d]pyrimidin-4-one

C18H12N2OS2 (336.0391)


   

ethyl 4-acetyloxy-7-bromonaphthalene-2-carboxylate

ethyl 4-acetyloxy-7-bromonaphthalene-2-carboxylate

C15H13BrO4 (335.9997)


   

Ethyl 4-acetoxy-6-bromo-2-naphthoate

Ethyl 4-acetoxy-6-bromo-2-naphthoate

C15H13BrO4 (335.9997)


   

3-[2-Chloro-4-(5-nitrothiazol-2-ylazo)anilino]propiononitrile

3-[2-Chloro-4-(5-nitrothiazol-2-ylazo)anilino]propiononitrile

C12H9ClN6O2S (336.0196)


   

2-Bromo-9-phenyl-9H-fluoren-9-ol

2-Bromo-9-phenyl-9H-fluoren-9-ol

C19H13BrO (336.015)


   

3-BROMO-2-(3-METHOXYBENZYLOXY)PHENYLBO&

3-BROMO-2-(3-METHOXYBENZYLOXY)PHENYLBO&

C14H14BBrO4 (336.0168)


   

2-(3-Methoxyphenylthio)-1-(4-bromophenyl)ethanone

2-(3-Methoxyphenylthio)-1-(4-bromophenyl)ethanone

C15H13BrO2S (335.982)


   

2-(t-Butyldimethylsilyloxy)-6-bromonaphthalene

2-(t-Butyldimethylsilyloxy)-6-bromonaphthalene

C16H21BrOSi (336.0545)


   

Disulfide,bis(4-methyl-2-nitrophenyl)

Disulfide,bis(4-methyl-2-nitrophenyl)

C14H12N2O4S2 (336.0238)


   

4-Butyl-4-iodobiphenyl

4-Butyl-4-iodobiphenyl

C16H17I (336.0375)


   

3-(BENZOYLOXY)-5-BROMO-2-HYDROXYBENZOIC ACID

3-(BENZOYLOXY)-5-BROMO-2-HYDROXYBENZOIC ACID

C14H9BrO5 (335.9633)


   

2-Bromo-7-(2-methyl-2-propanyl)pyrene

2-Bromo-7-(2-methyl-2-propanyl)pyrene

C20H17Br (336.0514)


   

7-BENZYLOXY-4-CHLORO-6-METHOXY-QUINAZOLINE HYDROCHLORIDE

7-BENZYLOXY-4-CHLORO-6-METHOXY-QUINAZOLINE HYDROCHLORIDE

C16H14Cl2N2O2 (336.0432)


   

sodium 1,1,3,3,3-pentafluoro-2-(pivaloyloxy)propane-1-sulfonate

sodium 1,1,3,3,3-pentafluoro-2-(pivaloyloxy)propane-1-sulfonate

C8H10F5NaO5S (336.0067)


   

[acetyloxy-(4-methylphenyl)-λ3-iodanyl] acetate

[acetyloxy-(4-methylphenyl)-λ3-iodanyl] acetate

C11H13IO4 (335.9859)


   

(3S,4R)-3-benzyloxycarbonylamino-4-methyl-2-oxoazetidine-1-sulphonic acid sodium salt

(3S,4R)-3-benzyloxycarbonylamino-4-methyl-2-oxoazetidine-1-sulphonic acid sodium salt

C12H13N2NaO6S (336.0392)


   

Calcium benzoate

Calcium benzoate

C14H16CaO7 (336.0522)


Preservative, used in margarine.

   

1-BENZYL-3-((DIMETHYLCARBAMOYL)OXY)PYRIDIN-1-IUM BROMIDE

1-BENZYL-3-((DIMETHYLCARBAMOYL)OXY)PYRIDIN-1-IUM BROMIDE

C15H17BrN2O2 (336.0473)


   
   

disodium,[(2R)-2-[(1S)-1,2-dihydroxyethyl]-3-oxido-5-oxo-2H-furan-4-yl] sulfate

disodium,[(2R)-2-[(1S)-1,2-dihydroxyethyl]-3-oxido-5-oxo-2H-furan-4-yl] sulfate

C6H10Na2O11S (335.9739)


   

Cephalonium lactone

Cephalonium lactone

C14H12N2O4S2 (336.0238)


   

Pyridinium, 3-[(methoxycarbonyl)amino]-4-methyl-1-(phenylmethyl)-, bromide

Pyridinium, 3-[(methoxycarbonyl)amino]-4-methyl-1-(phenylmethyl)-, bromide

C15H17BrN2O2 (336.0473)


   

PERFLUORO(1,3,5-TRIMETHYLBENZENE)

PERFLUORO(1,3,5-TRIMETHYLBENZENE)

C9F12 (335.9808)


   

14H-Anthra[2,1,9-mna]thioxanthen-14-one

14H-Anthra[2,1,9-mna]thioxanthen-14-one

C23H12OS (336.0609)


   

3-(3-Bromophenyl)-4-(4-chlorophenyl)butan-2-one

3-(3-Bromophenyl)-4-(4-chlorophenyl)butan-2-one

C16H14BrClO (335.9916)


   

2-Bromo-N-(4-methoxybenzyl)-6-nitroaniline

2-Bromo-N-(4-methoxybenzyl)-6-nitroaniline

C14H13BrN2O3 (336.0109)


   

Nifurzide

5-nitro-N-[(E)-[(E)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]thiophene-2-carboxamide

C12H8N4O6S (336.0165)


A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent

   

(S)-HOMO-BETA-VALINE

(S)-HOMO-BETA-VALINE

C12H11F3N2O6 (336.0569)


   

3-(4-CHLORO-PHENYL)-7H-[1,2,4]TRIAZOLO[3,4-B][1,3,4]THIADIAZIN-6-YL]-ACETIC ACID ETHYL ESTER

3-(4-CHLORO-PHENYL)-7H-[1,2,4]TRIAZOLO[3,4-B][1,3,4]THIADIAZIN-6-YL]-ACETIC ACID ETHYL ESTER

C14H13ClN4O2S (336.0448)


   

METHYL 3-(N-(4-CHLORO-3-METHYLISOXAZOL-5-YL)SULFAMOYL)THIOPHENE-2-CARBOXYLATE

METHYL 3-(N-(4-CHLORO-3-METHYLISOXAZOL-5-YL)SULFAMOYL)THIOPHENE-2-CARBOXYLATE

C10H9ClN2O5S2 (335.9641)


   

2-Bromo-N-(4-methoxybenzyl)-4-nitroaniline

2-Bromo-N-(4-methoxybenzyl)-4-nitroaniline

C14H13BrN2O3 (336.0109)


   

5-Amino-4-cyano-3-[[(4-fluorophenyl)thio]methyl]-2-thiophenecarboxylic acid ethyl ester

5-Amino-4-cyano-3-[[(4-fluorophenyl)thio]methyl]-2-thiophenecarboxylic acid ethyl ester

C15H13FN2O2S2 (336.0402)


   

3-Bromo-N-(4-methoxybenzyl)-2-nitroaniline

3-Bromo-N-(4-methoxybenzyl)-2-nitroaniline

C14H13BrN2O3 (336.0109)


   

2-Iodo-5-methyl-3-(5-pyrimidinyl)-1H-pyrrolo[2,3-b]pyridine

2-Iodo-5-methyl-3-(5-pyrimidinyl)-1H-pyrrolo[2,3-b]pyridine

C12H9IN4 (335.9872)


   

2,6-BIS-(4-CHLORO-PHENYL)-TETRAHYDRO-THIOPYRAN-4-ONE

2,6-BIS-(4-CHLORO-PHENYL)-TETRAHYDRO-THIOPYRAN-4-ONE

C17H14Cl2OS (336.0142)


   

ethyl 6-bromo-8-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate

ethyl 6-bromo-8-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate

C11H8BrF3N2O2 (335.9721)


   

Ethyl 5-iodo-2,4-dimethoxybenzoate

Ethyl 5-iodo-2,4-dimethoxybenzoate

C11H13IO4 (335.9859)


   

2-Bromo-4-methoxy-5-benzyloxybenzoic acid

2-Bromo-4-methoxy-5-benzyloxybenzoic acid

C15H13BrO4 (335.9997)


   

Benzo[b]thiophen-2-yl(5-bromo-2-fluorophenyl)methanol

Benzo[b]thiophen-2-yl(5-bromo-2-fluorophenyl)methanol

C15H10BrFOS (335.962)


   

6-METHYL-2,4,6-TRIS(TRIFLUOROMETHYL)TETRAHYDROPYRAN-2,4-DIOL

6-METHYL-2,4,6-TRIS(TRIFLUOROMETHYL)TETRAHYDROPYRAN-2,4-DIOL

C9H9F9O3 (336.0408)


   

SODIUM 2,2,3,3,4,4,5,5,6,6,6-UNDECAFLUOROHEXANOATE

SODIUM 2,2,3,3,4,4,5,5,6,6,6-UNDECAFLUOROHEXANOATE

C6F11NaO2 (335.962)


   

N-CARBOBENZOXY-2-NITROBENZENESULFONAMIDE

N-CARBOBENZOXY-2-NITROBENZENESULFONAMIDE

C14H12N2O6S (336.0416)


   

2,4-DINITRO(HEPTAFLUOROISOPROPYL)BENZENE

2,4-DINITRO(HEPTAFLUOROISOPROPYL)BENZENE

C9H3F7N2O4 (335.9981)


   

tantalum(v) methoxide

tantalum(v) methoxide

C5H15O5Ta (336.04)


   

4-Benzoyl-4-bromobiphenyl

4-Benzoyl-4-bromobiphenyl

C19H13BrO (336.015)


   

1-[(4-bromo-2-fluorophenyl)sulfonyl]-4-methylpiperazine

1-[(4-bromo-2-fluorophenyl)sulfonyl]-4-methylpiperazine

C11H14BrFN2O2S (335.9943)


   

Recilisib

Recilisib

C16H13ClO4S (336.0223)


Recilisib (ON 01210) is a radioprotectant, which can activate AKT, PI3K activities in cells[1].

   

9-(3-bromophenyl)-9H-fluorene-9-ol

9-(3-bromophenyl)-9H-fluorene-9-ol

C19H13BrO (336.015)


   

Potassium bis(1,2-benzenediolato)(1,3-butadien-2-yl)silicate, min. 98

Potassium bis(1,2-benzenediolato)(1,3-butadien-2-yl)silicate, min. 98

C16H13KO4Si (336.022)


   

4-bromo-N-[(4-methoxyphenyl)methyl]-2-nitroaniline

4-bromo-N-[(4-methoxyphenyl)methyl]-2-nitroaniline

C14H13BrN2O3 (336.0109)


   

ethyl 6-broMo-2-(trifluoroMethyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylate

ethyl 6-broMo-2-(trifluoroMethyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylate

C11H8BrF3N2O2 (335.9721)


   

ethyl 5-broMo-2-(trifluoroMethyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylate

ethyl 5-broMo-2-(trifluoroMethyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylate

C11H8BrF3N2O2 (335.9721)


   

METHYL N-BOC-2-AMINO-5-BROMOTHIAZOLE-4-CARBOXYLATE

METHYL N-BOC-2-AMINO-5-BROMOTHIAZOLE-4-CARBOXYLATE

C10H13BrN2O4S (335.9779)


   

Gallocyanine

Gallocyanine

C15H13ClN2O5 (336.0513)


D004396 - Coloring Agents

   

cyclopentadienylrhenium tricarbonyl

cyclopentadienylrhenium tricarbonyl

C8H5O3Re (335.9796)


   

N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine

N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine

C14H7ClF2N4O2 (336.0226)


   

3-chloro-5-phenylmethoxy-1-benzothiophene-2-carbonyl chloride

3-chloro-5-phenylmethoxy-1-benzothiophene-2-carbonyl chloride

C16H10Cl2O2S (335.9779)


   

calcium,dibenzoate,trihydrate

calcium,dibenzoate,trihydrate

C14H16CaO7 (336.0522)


   

1-tert-butylperoxy-1λ3,2-benziodoxol-3-one

1-tert-butylperoxy-1λ3,2-benziodoxol-3-one

C11H13IO4 (335.9859)


   

Cysteine, S-[4-[bis(2-chloroethyl)amino]phenyl]-

Cysteine, S-[4-[bis(2-chloroethyl)amino]phenyl]-

C13H18Cl2N2O2S (336.0466)


   

4-(2-Ethoxyethoxy)-3-iodobenzoic acid

4-(2-Ethoxyethoxy)-3-iodobenzoic acid

C11H13IO4 (335.9859)


   

3,4,5,3,4,5-Hexahydroxydiphenate

3,4,5,3,4,5-Hexahydroxydiphenate

C14H8O10-2 (336.0117)


   

3,6-dichloro-N-(4-methyl-2-pyridinyl)-1-benzothiophene-2-carboxamide

3,6-dichloro-N-(4-methyl-2-pyridinyl)-1-benzothiophene-2-carboxamide

C15H10Cl2N2OS (335.9891)


   

(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-methylsulfonylprop-2-enenitrile

(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-methylsulfonylprop-2-enenitrile

C14H12N2O4S2 (336.0238)


   

2-(2,4-Dichlorophenyl)-5-[2-(methylthio)phenyl]-1,3,4-oxadiazole

2-(2,4-Dichlorophenyl)-5-[2-(methylthio)phenyl]-1,3,4-oxadiazole

C15H10Cl2N2OS (335.9891)


   

Tridecafluorohexan-1-ol

Tridecafluorohexan-1-ol

C6HF13O (335.982)


   

2,4,6-Trichloro-6-phenyl-5,4-bipyrimidine

2,4,6-Trichloro-6-phenyl-5,4-bipyrimidine

C14H7Cl3N4 (335.9736)


   

EDTA disodium salt

Ethylenediaminetetraacetic acid disodium salt

C10H14N2Na2O8 (336.0546)


D064449 - Sequestering Agents > D002614 - Chelating Agents > D065096 - Calcium Chelating Agents C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent D000074385 - Food Ingredients > D005503 - Food Additives D006401 - Hematologic Agents > D000925 - Anticoagulants

   

Thiamine hydrochloride

Thiamine hydrochloride

C12H18Cl2N4OS (336.0578)


Thiamine hydrochloride (Thiamine chloride hydrochloride) is an essential micronutrient needed as a cofactor for many central metabolic enzymes. Thiamine hydrochloride (Thiamine chloride hydrochloride) is an essential micronutrient needed as a cofactor for many central metabolic enzymes.

   

beta-D-fructose 2,6-bisphosphate

[3,4-Dihydroxy-5-(hydroxymethyl)-5-(phosphonatooxy)oxolan-2-yl]methyl phosphoric acid

C6H10O12P2 (335.9648)


beta-d-fructose 2,6-bisphosphate is soluble (in water) and an extremely strong acidic compound (based on its pKa). beta-d-fructose 2,6-bisphosphate can be found in a number of food items such as chinese mustard, mexican oregano, chickpea, and saskatoon berry, which makes beta-d-fructose 2,6-bisphosphate a potential biomarker for the consumption of these food products. β-d-fructose 2,6-bisphosphate is soluble (in water) and an extremely strong acidic compound (based on its pKa). β-d-fructose 2,6-bisphosphate can be found in a number of food items such as chinese mustard, mexican oregano, chickpea, and saskatoon berry, which makes β-d-fructose 2,6-bisphosphate a potential biomarker for the consumption of these food products.

   

Peonidin chloride

Peonidin 3-[4-hydroxycinnamoyl-b-D-glucopyranoside]

C16H13ClO6 (336.0401)


Isolated from grapes. Peonidin 3-[4-hydroxycinnamoyl-b-D-glucopyranoside] is found in many foods, some of which are fruits, olive, common grape, and rose hip.

   

[3,4-Dihydroxy-2-(hydroxymethyl)-5-(phosphonatooxymethyl)oxolan-2-yl] phosphate

[3,4-Dihydroxy-2-(hydroxymethyl)-5-(phosphonatooxymethyl)oxolan-2-yl] phosphate

C6H10O12P2-4 (335.9648)


   

5-amino-1-(5-phosphonato-D-ribosyl)imidazole-4-carboxylate

5-amino-1-(5-phosphonato-D-ribosyl)imidazole-4-carboxylate

C9H11N3O9P-3 (336.0233)


   

beta-D-fructofuranose 1,6-bisphosphate(4-)

beta-D-fructofuranose 1,6-bisphosphate(4-)

C6H10O12P2-4 (335.9648)


D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D007155 - Immunologic Factors D020011 - Protective Agents

   

D-tagatofuranose 1,6-bisphosphate(4-)

D-tagatofuranose 1,6-bisphosphate(4-)

C6H10O12P2-4 (335.9648)


   

alpha-D-glucose 1,6-bisphosphate(4-)

alpha-D-glucose 1,6-bisphosphate(4-)

C6H10O12P2-4 (335.9648)


   

beta-D-Fructose 2,6-bisphosphate

beta-D-Fructose 2,6-bisphosphate

C6H10O12P2-4 (335.9648)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

1D-myo-inositol 3,4-biphosphate(4-)

1D-myo-inositol 3,4-biphosphate(4-)

C6H10O12P2-4 (335.9648)


   

5-carboxylatoamino-1-(5-O-phosphonato-D-ribosyl)imidazole(3-)

5-carboxylatoamino-1-(5-O-phosphonato-D-ribosyl)imidazole(3-)

C9H11N3O9P-3 (336.0233)


   

Inositol 1,4-bis(phosphate)

Inositol 1,4-bis(phosphate)

C6H10O12P2-4 (335.9648)


   

5-amino-1-(5-phospho-D-Ribosyl)imidazole-4-carboxamide

5-amino-1-(5-phospho-D-Ribosyl)imidazole-4-carboxamide

C9H13N4O8P-2 (336.0471)


COVID info from COVID-19 Disease Map D007004 - Hypoglycemic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

1D-Myo-inositol 1,3-bisphosphate

1D-Myo-inositol 1,3-bisphosphate

C6H10O12P2-4 (335.9648)


   

6-(2-Azaniumyl-2-carboxylatoethyl)-7,8-dioxo-1,2,3,4,7,8-hexahydroquinoline-2,4-dicarboxylate

6-(2-Azaniumyl-2-carboxylatoethyl)-7,8-dioxo-1,2,3,4,7,8-hexahydroquinoline-2,4-dicarboxylate

C14H12N2O8-2 (336.0594)


   

1D-myo-inositol 1,2-bisphosphate

1D-myo-inositol 1,2-bisphosphate

C6H10O12P2-4 (335.9648)


   

Inositol (2,5) bisphosphate

Inositol (2,5) bisphosphate

C6H10O12P2-4 (335.9648)


   

1D-myo-inositol (2,4) bisphosphate

1D-myo-inositol (2,4) bisphosphate

C6H10O12P2-4 (335.9648)


   

beta-Glucose 1,6-bisphosphate

beta-Glucose 1,6-bisphosphate

C6H10O12P2-4 (335.9648)


   

Inositol (3,6)-bisphosphate

Inositol (3,6)-bisphosphate

C6H10O12P2-4 (335.9648)


   

Glucose-1,6-diphosphate

Glucose-1,6-diphosphate

C6H10O12P2-4 (335.9648)


   

Glucosamine 1,6-diphosphate

Glucosamine 1,6-diphosphate

C6H12NO11P2-3 (335.9886)


   

Desmethyl-dehydrogriseofulvin

Desmethyl-dehydrogriseofulvin

C16H13ClO6 (336.0401)


   

2-O-acetyl-3-O-trans-coutarate

2-O-acetyl-3-O-trans-coutarate

C15H12O9-2 (336.0481)


   

D-myo-inositol (4,5)-bisphosphate

D-myo-inositol (4,5)-bisphosphate

C6H10O12P2-4 (335.9648)


   

7,10-Diketo-pre-bikaverin

7,10-Diketo-pre-bikaverin

C18H8O7-2 (336.027)


   

1-[3,4-Dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxylic acid

1-[3,4-Dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxylic acid

C11H15NO9P+ (336.0484)


   

EDTA disodium

Ethylenediaminetetraacetic acid disodium salt

C10H14N2Na2O8 (336.0546)


D064449 - Sequestering Agents > D002614 - Chelating Agents > D065096 - Calcium Chelating Agents C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent D000074385 - Food Ingredients > D005503 - Food Additives D006401 - Hematologic Agents > D000925 - Anticoagulants

   

N-(3-chlorophenyl)-2-oxo-3,4-dihydro-1H-quinoline-6-sulfonamide

N-(3-chlorophenyl)-2-oxo-3,4-dihydro-1H-quinoline-6-sulfonamide

C15H13ClN2O3S (336.0335)


   

2-[(2-Phenyl-4-benzofuro[3,2-d]pyrimidinyl)thio]acetic acid

2-[(2-Phenyl-4-benzofuro[3,2-d]pyrimidinyl)thio]acetic acid

C18H12N2O3S (336.0569)


   

3,6-dichloro-N-(3-pyridinylmethyl)-1-benzothiophene-2-carboxamide

3,6-dichloro-N-(3-pyridinylmethyl)-1-benzothiophene-2-carboxamide

C15H10Cl2N2OS (335.9891)


   

D-glucose 1,6-bisphosphate(4-)

D-glucose 1,6-bisphosphate(4-)

C6H10O12P2-4 (335.9648)


   

N-(3-fluoro-4-methylphenyl)-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide

N-(3-fluoro-4-methylphenyl)-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide

C15H13FN2O4S (336.058)


   

D-fructofuranose 1,6-bisphosphate(4-)

D-fructofuranose 1,6-bisphosphate(4-)

C6H10O12P2-4 (335.9648)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

1-[2-[(4-Chlorophenyl)thio]ethyl]-3-(4-methylphenyl)thiourea

1-[2-[(4-Chlorophenyl)thio]ethyl]-3-(4-methylphenyl)thiourea

C16H17ClN2S2 (336.0522)


   

2-[(2-Chlorophenyl)methylthio]-6-nitro-1,3-benzothiazole

2-[(2-Chlorophenyl)methylthio]-6-nitro-1,3-benzothiazole

C14H9ClN2O2S2 (335.9794)


   

2-Methyl-1-cyclopropanecarboxylic acid (7-bromo-4-oxo-2-pyrido[1,2-a]pyrimidinyl)methyl ester

2-Methyl-1-cyclopropanecarboxylic acid (7-bromo-4-oxo-2-pyrido[1,2-a]pyrimidinyl)methyl ester

C14H13BrN2O3 (336.0109)


   

5-Hydroxymethyluridine-2-deoxy-5-phosphate(2-)

5-Hydroxymethyluridine-2-deoxy-5-phosphate(2-)

C10H13N2O9P-2 (336.0359)


   

4-[2-[(4-Chlorophenyl)thio]ethoxy]-3-ethoxybenzaldehyde

4-[2-[(4-Chlorophenyl)thio]ethoxy]-3-ethoxybenzaldehyde

C17H17ClO3S (336.0587)


   

5-bromo-N-[(2-pyridinylamino)-sulfanylidenemethyl]-3-pyridinecarboxamide

5-bromo-N-[(2-pyridinylamino)-sulfanylidenemethyl]-3-pyridinecarboxamide

C12H9BrN4OS (335.968)


   

5-methyl-5-O-phosphonatouridine

5-methyl-5-O-phosphonatouridine

C10H13N2O9P-2 (336.0359)


   

alpha-D-mannose 1,6-bisphosphate

alpha-D-mannose 1,6-bisphosphate

C6H10O12P2-4 (335.9648)


   

1D-myo-inositol 3,5-bisphosphate(4-)

1D-myo-inositol 3,5-bisphosphate(4-)

C6H10O12P2-4 (335.9648)


   

alpha-D-fructofuranose 1,6-bisphosphate(4-)

alpha-D-fructofuranose 1,6-bisphosphate(4-)

C6H10O12P2-4 (335.9648)


   

griseophenone B(2-)

griseophenone B(2-)

C16H13ClO6-2 (336.0401)


   

1D-myo-inositol 2,3-bisphosphate

1D-myo-inositol 2,3-bisphosphate

C6H10O12P2-4 (335.9648)


   

[(2S,3R,4S,5R,6R)-2,3,5-trihydroxy-6-(phosphonatooxymethyl)oxan-4-yl] phosphate

[(2S,3R,4S,5R,6R)-2,3,5-trihydroxy-6-(phosphonatooxymethyl)oxan-4-yl] phosphate

C6H10O12P2-4 (335.9648)


   

Nicotinate mononucleotide

Nicotinate mononucleotide

C11H15NO9P+ (336.0484)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Bisphenol AF

Hexafluorobisphenol A

C15H10F6O2 (336.0585)


An organofluorine compound that is bisphenol A with its methyl hydrogens replaced by fluorines. D052244 - Endocrine Disruptors

   

5-amino-1-(5-phosphonato-D-ribosyl)imidazole-4-carboxylate

5-amino-1-(5-phosphonato-D-ribosyl)imidazole-4-carboxylate

C9H11N3O9P (336.0233)


Trianion of 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid.

   

beta-D-fructofuranose 1,6-bisphosphate(4-)

beta-D-fructofuranose 1,6-bisphosphate(4-)

C6H10O12P2 (335.9648)


A D-fructofuranose 1,6-bisphosphate(4-) that is the conjugate base of beta-D-fructofuranose 1,6-bisphosphate.

   

alpha-D-glucose 1,6-bisphosphate(4-)

alpha-D-glucose 1,6-bisphosphate(4-)

C6H10O12P2 (335.9648)


A quadruply-charged organophosphate oxoanion arising from deprotonation of the phosphate OH groups of alpha-D-glucose 1,6-bisphosphate; major species at pH 7.3.

   

beta-D-fructofuranose 2,6-bisphosphate(4-)

beta-D-fructofuranose 2,6-bisphosphate(4-)

C6H10O12P2 (335.9648)


An organophosphate oxoanion that is the tetraanion of beta-D-fructofuranose 2,6-bisphosphate.

   

5-carboxylatoamino-1-(5-O-phosphonato-D-ribosyl)imidazole(3-)

5-carboxylatoamino-1-(5-O-phosphonato-D-ribosyl)imidazole(3-)

C9H11N3O9P (336.0233)


Trianion of 5-carboxyamino-1-(5-phospho-D-ribosyl)imidazole arising from deprotonation of phosphate and carbamic acid functions.

   

nbqx

2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

C12H8N4O6S (336.0165)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002491 - Central Nervous System Agents > D000927 - Anticonvulsants NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist. NBQX has neuroprotective and anticonvulsant activity[1].

   

4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-methyl-O-sulphate

4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-methyl-O-sulphate

C12H16O9S (336.0515)


   

D-fructofuranose 1,6-bisphosphate(4-)

D-fructofuranose 1,6-bisphosphate(4-)

C6H10O12P2 (335.9648)


An organophosphate oxoanion obtained by removal of all four protons from the phosphate OH groups of D-fructofuranose 1,6-bisphosphate.

   

alpha-D-fructofuranose 1,6-bisphosphate(4-)

alpha-D-fructofuranose 1,6-bisphosphate(4-)

C6H10O12P2 (335.9648)


A D-fructofuranose 1,6-bisphosphate(4-) that is the conjugate base of alpha-D-fructofuranose 1,6-bisphosphate.

   

5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)

5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)

C9H13N4O8P (336.0471)


An organophosphate oxoanion resulting from the removal of both protons from the phosphate group of 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide. It is the major species at pH 7.3.

   

Nicotinic acid D-ribonucleotide

Nicotinic acid D-ribonucleotide

C11H15NO9P (336.0484)


A D-ribonucleotide having nicotinic acid as the nucleobase.

   

D-tagatofuranose 1,6-bisphosphate(4-)

D-tagatofuranose 1,6-bisphosphate(4-)

C6H10O12P2 (335.9648)


A organophosphate oxoanion that is the tetraanion of D-tagatofuranose 1,6-bisphosphate.

   

1D-myo-inositol 1,4-bisphosphate(4-)

1D-myo-inositol 1,4-bisphosphate(4-)

C6H10O12P2 (335.9648)


An organophosphate oxoanion arising from deprotonation of the phosphate OH groups of 1D-myo-inositol 1,4-bisphosphate; major species at pH 7.3.

   

1D-myo-inositol 3,4-biphosphate(4-)

1D-myo-inositol 3,4-biphosphate(4-)

C6H10O12P2 (335.9648)


An inositol phosphate oxoanion obtained by deprotonation of the phospho groups of 1D-myo-inositol 3,4-biphosphate; major species at pH 7.3.

   

1D-myo-inositol 1,3-biphosphate(4-)

1D-myo-inositol 1,3-biphosphate(4-)

C6H10O12P2 (335.9648)


An inositol phosphate oxoanion obtained by deprotonation of the phospho groups of 1D-myo-inositol 1,3-biphosphate; major species at pH 7.3.

   

6-nitro-2,3-dioxo-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide

6-nitro-2,3-dioxo-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide

C12H8N4O6S (336.0165)


   

ADRA1D receptor antagonist 1

ADRA1D receptor antagonist 1

C15H14Cl2N4O (336.0545)


ADRA1D receptor antagonist 1 is a potent, selective and orally active α1D adrenoceptor antagonist, with a Ki of 1.6 nM[1].

   

MSNBA

MSNBA

C14H12N2O6S (336.0416)


MSNBA is a specific inhibitor of GLUT5 fructose transport in proteoliposomes. MSNBA competitively inhibits GLUT5 fructose uptake with a KI of 3.2±0.4?μM in MCF7 cells[1].

   

(5r)-4-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-5-methoxy-5-methylfuran-2-one

(5r)-4-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-5-methoxy-5-methylfuran-2-one

C13H18BrClO3 (336.0128)


   

(2s,6's)-3',11'-dichloro-4-methyl-6'-(methylamino)-2'-azaspiro[furan-2,7'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3',8'(12'),9'-tetraen-5-one

(2s,6's)-3',11'-dichloro-4-methyl-6'-(methylamino)-2'-azaspiro[furan-2,7'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3',8'(12'),9'-tetraen-5-one

C16H14Cl2N2O2 (336.0432)


   

1,2,3,4,5,6,7,8-octahydro-9,10-dimethyl anthracene

NA

C14H8O10 (336.0117)


{"Ingredient_id": "HBIN000566","Ingredient_name": "1,2,3,4,5,6,7,8-octahydro-9,10-dimethyl anthracene","Alias": "NA","Ingredient_formula": "C14H8O10","Ingredient_Smile": "C12=C(C(=C(C(=C1O)O)O)O)C(=O)C3=C(C2=O)C(=C(C(=C3O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41326","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

4,4'-dimethoxy-1,1'-dimethyl-[3,3'-bipyridine]-2,2',5,5',6,6'-hexone

4,4'-dimethoxy-1,1'-dimethyl-[3,3'-bipyridine]-2,2',5,5',6,6'-hexone

C14H12N2O8 (336.0594)


   

methyl (2z)-3-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-4-oxopent-2-enoate

methyl (2z)-3-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-4-oxopent-2-enoate

C13H18BrClO3 (336.0128)


   

(5s)-4-[(1r,3r,4r)-3-bromo-4-chloro-4-methylcyclohexyl]-5-methoxy-5-methylfuran-2-one

(5s)-4-[(1r,3r,4r)-3-bromo-4-chloro-4-methylcyclohexyl]-5-methoxy-5-methylfuran-2-one

C13H18BrClO3 (336.0128)


   

4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-methoxy-5-methylfuran-2-one

4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-methoxy-5-methylfuran-2-one

C13H18BrClO3 (336.0128)


   

(5r)-4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-methoxy-5-methylfuran-2-one

(5r)-4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-methoxy-5-methylfuran-2-one

C13H18BrClO3 (336.0128)


   

3',11'-dichloro-4-methyl-6'-(methylamino)-2'-azaspiro[furan-2,7'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3',8'(12'),9'-tetraen-5-one

3',11'-dichloro-4-methyl-6'-(methylamino)-2'-azaspiro[furan-2,7'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3',8'(12'),9'-tetraen-5-one

C16H14Cl2N2O2 (336.0432)


   

methyl 3-(3-bromo-4-chloro-4-methylcyclohexyl)-4-oxopent-2-enoate

methyl 3-(3-bromo-4-chloro-4-methylcyclohexyl)-4-oxopent-2-enoate

C13H18BrClO3 (336.0128)


   

(5r)-4-[(1r,3r,4r)-3-bromo-4-chloro-4-methylcyclohexyl]-5-methoxy-5-methylfuran-2-one

(5r)-4-[(1r,3r,4r)-3-bromo-4-chloro-4-methylcyclohexyl]-5-methoxy-5-methylfuran-2-one

C13H18BrClO3 (336.0128)


   

8-hydroxy-6-methoxy-1-methyl-9-oxoxanthene-3-sulfonic acid

8-hydroxy-6-methoxy-1-methyl-9-oxoxanthene-3-sulfonic acid

C15H12O7S (336.0304)


   

(2s,6'r)-3',11'-dichloro-4-methyl-6'-(methylamino)-2'-azaspiro[furan-2,7'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3',8'(12'),9'-tetraen-5-one

(2s,6'r)-3',11'-dichloro-4-methyl-6'-(methylamino)-2'-azaspiro[furan-2,7'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3',8'(12'),9'-tetraen-5-one

C16H14Cl2N2O2 (336.0432)


   

5,13-dichloro-10-hydroxy-4-methyl-2-oxa-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaene-7-carboximidic acid

5,13-dichloro-10-hydroxy-4-methyl-2-oxa-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaene-7-carboximidic acid

C15H10Cl2N2O3 (336.0068)


   

(5s)-4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-methoxy-5-methylfuran-2-one

(5s)-4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-methoxy-5-methylfuran-2-one

C13H18BrClO3 (336.0128)


   

methyl (2z)-3-[(1r,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-4-oxopent-2-enoate

methyl (2z)-3-[(1r,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-4-oxopent-2-enoate

C13H18BrClO3 (336.0128)